{
  "variant_id": {
    "Gene": "F2",
    "Protein_Change": {
      "ref": "A",
      "alt": "G",
      "position": "20210"
    },
    "variant_string_id": "F2 G20210A"
  },
  "functional_evidence_aim": "Pathogenic",
  "assessment_steps": [
    {
      "step_name": "Step 1: Define the disease mechanism",
      "extracted_paper_info": "The variant G20210A is associated with an increased risk of venous thromboembolism (VTE).",
      "judgment": "Yes"
    },
    {
      "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
      "extracted_paper_info": "The assay measures the effect of G20210A on factor II protein function.",
      "judgment": "Yes"
    },
    {
      "step_name": "Step 3a: Basic Controls and Replicates",
      "extracted_paper_info": "Normal/Negative/Wild type and abnormal/Positive/Null controls were used, and multiple replicates (n=3) were performed.",
      "judgment": "Yes"
    },
    {
      "step_name": "Step 4a: Statistical Analyses",
      "extracted_paper_info": "The paper includes statistical analyses that estimate or calculate OddsPath for the functional data for this variant.",
      "judgment": "Yes"
    }
  ],
  "final_evidence_strength": {
    "type": "Pathogenic",
    "strength": "PS3_moderate"
  },
  "overall_conclusion": "The functional assay used in this study effectively modeled or reflected the disease pathogenesis/mechanism defined in Step 1, and the statistical analyses were sufficient to estimate OddsPath for the functional data for this variant. Based on the ACMG guidelines for OddsPath interpretation, the final evidence strength is PS3_moderate."
}